Navigation Links
Vi typhoid vaccine proves highly effective in young children
Date:7/22/2009

ceptionally high risk in the poorest settings. There are also doubts about Vi's ability to confer "herd protection," or protection of unvaccinated residents living in highly vaccinated areas.

To address these uncertainties, the IVI in collaboration with NICED conducted a phase 4 cluster-randomized effectiveness trial, which randomized 80 geographic clusters of an urban Kolkata slum to either Vi or a control vaccine. Over two years of follow-up, the Vi group was shown to have 61 percent fewer episodes of typhoid than the control group. Protection of vaccinated children under five years of age by Vi was even higher, 80%. Interestingly, unvaccinated neighbors of Vi vaccinated persons had a 44 percent lower risk of typhoid, indicating that Vi vaccine conferred substantial herd protection. The overall level of protection among all residents of the Vi clusters, regardless of whether they were vaccinated was 57 percent. Since the coverage of residents of the Vi clusters was about 60%, this observation indicates that Vi vaccine prevented as many cases of typhoid in the total population as a vaccine that was nearly 100% protective in vaccinated persons.

"The protection for children under the age of five years is important because this age group has been shown to be at high risk for typhoid fever in many areas where the disease is endemic," said Dr. John Clemens, Director-General of the IVI and an international expert in vaccine evaluation. In a separate IVI study conducted in five Asian countries and supported by the Bill and Melinda Gates Foundation, children less than five years of age were found to have high rates of typhoid in Kolkata, India, Jakarta, Indonesia and Karachi, Pakistan, confirming that the disease is not limited to school-aged children and adults.

The IVI-NICED study, which was supported by the Gates Foundation and the governments of Korea, Sweden, and Kuwait, also revealed that delivering the low-cost Vi typhoid vaccine is l
'/>"/>

Contact: Tae Kyung Byun
tkbyun@ivi.int
82-119-773-6071
International Vaccine Institute
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
4. Anthrax vaccine produces immunity with nanoparticles, not needles
5. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
6. International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development
7. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
8. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
9. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
10. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
11. New nanoparticle vaccine is more effective but less expensive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 /PRNewswire/ - SQI Diagnostics Inc. ... diagnostics company that develops and commercializes proprietary technologies ... announced that it has received approval from the ... 5,126,044 outstanding common share purchase warrants ("the Warrants") ... with the Company,s May 2013 private placement financing. ...
(Date:4/17/2015)... 17, 2015 Global Stem Cells ... Stem Cell Summit 2015 April 27 - 29, 2015 ... developments in all areas of stem cell research including ... cells and regenerative medicine. , The conference will ... well as translational research in stem cell therapies, regenerative ...
(Date:4/16/2015)... South Carolina (PRWEB) April 17, 2015 ... and steam system services, released their newly designed, ... The customer facing website effectively promotes the ... , All the information that a site ... steam system services, company capabilities, industries serviced, the ...
(Date:4/16/2015)... South San Francisco, CA (PRWEB) April 16, 2015 ... it is scheduled to report first quarter results on ... Following the announcement, Cytokinetics’ senior management will host a ... operational and financial results and the company’s outlook for ... webcast and can be accessed from the homepage and ...
Breaking Biology Technology:SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 3Spirax Sarco website has a new look 2Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3
... 8 LifeNet Health, a leading allograft bio-implant company, ... Tendon, both offering new options for ligament reconstruction. ... new bio-medical implants offer sports medicine physicians another alternative ... Tendon can be used in the reconstruction of either ...
... Dec. 8 Building on its flagship,suite of ... the Pyxis(R) MedStation(R) 4000 and an industry-first Performance,Analytics ... help improve medication safety. , ... medication dispensing system,offers new features that can help ...
... in B-Precursor Acute Lymphoblastic Leukemia Show that Blinatumomab is ... , BETHESDA, Md., Dec. 8 ... company developing novel, proprietary antibodies for the treatment of ... data from a phase 2 clinical trial of BiTE(R) ...
Cached Biology Technology:LifeNet Health Introduces New Sports Medicine Bio-Implants 2Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data 2Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data 3Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias 2Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias 3Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias 4Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias 5
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)... March 23, 2015 SoundView Technology Group issues a ... NXTD ) Wocket smart wallet. SoundView was one of the ... their experience with the Wocket in multiple scenarios and outlets. ... Foods and other retailers, making both debit and credit card ... also says, "If the company meets their plans in 2015, ...
(Date:3/23/2015)... 2015  In the 2014 fiscal year, irs.gov recorded ... This figure accounts for a fraction of the estimated ... Report, exceeds $11 billion globally. The polygraph has traditionally ... has occurred. Investor Mark Saint Juste along ... Paolella partnered to administer the test in a ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... work and scientific adventure, marine explorers from more than ... Laboratory (MBL), today delivered the first global Census of ... and hides in the world,s oceans. In one of ... scientists spent over 9,000 days at sea on more ...
... survived for more than 400 million years, the horseshoe ... overharvest and habitat destruction. However, climatic changes may,also play ... how sensitive horseshoe crab populations are to natural climate ... Molecular Ecology . The horseshoe crab is ...
... Jerusalem, October 4, 2010 Researchers at the Hebrew University ... body that play a key role in controlling bone density, ... drug for prevention and treatment of osteoporosis and other bone ... researchers have just been published in the American journal ...
Cached Biology News:MBL scientists reveal findings of World Ocean Microbe Census 2MBL scientists reveal findings of World Ocean Microbe Census 3Climate change affects horseshoe crab numbers 2Hebrew University research holds promise for development of new osteoporosis drug 2
... an internal standard for the quantification of ... 5-OxoETE is a polyunsaturated keto acid formed ... neutrophils. It stimulates cytosolic calcium levels in ... 5-OxoETE selectively stimulates the migration and degranulation ...
... a 10.0 kb Autographa californica (AcNPV) polyhedrin ... AcNPV polyhedrin promoter and two AcNPV p10 ... a Sma I cloning site, followed by ... inverted polyhedrin promoter has been inserted containing ...
BD BioCoat Osteologic Coverslips that have been sterilized by ETO gas. Coating : Osteologic&trade ,Thickness : 0.16 mm ,Diameter : 12.7 mm ,Gridded : No ...
Mouse monoclonal antibody to ACP2 - acid phosphatase 2, lysosomal...
Biology Products: